Addex Therapeutics Ltd Operating Expense
Addex Therapeutics Ltd (ADXN) reported Operating Expense of CHF 769.27 thousand for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2025-09-30
- Addex Therapeutics Ltd operating expense for the quarter ending 2025-06-30 was 769.27K CHF, a 24.18% decline year-over-year.
- Addex Therapeutics Ltd operating expense for the quarter ending 2024-06-30 was 1.01M CHF, a 68.08% decline year-over-year.
- Addex Therapeutics Ltd operating expense for the quarter ending 2023-06-30 was 3.18M CHF, a 56.33% decline year-over-year.
- Addex Therapeutics Ltd operating expense for the quarter ending 2022-06-30 was 7.28M CHF, a 30.48% increase year-over-year.
| Period end | Operating Expense 3 month | Operating Expense 6 month | Operating Expense 12 month | Operating Expense 12 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | 769.27K CHF 6-K · filed 2025-09-30 | 1.45M CHF 6-K · filed 2025-09-30 | ||
| 2024-12-31 | 3.17M CHF 20-F · filed 2025-05-15 | |||
| 2024-06-30 | 1.01M CHF 6-K · filed 2025-09-30 | 2.04M CHF 6-K · filed 2025-09-30 | ||
| 2023-12-31 | 3.86M CHF 20-F · filed 2025-05-15 | 11.93M CHF 20-F · filed 2024-04-18 | ||
| 2023-06-30 | 3.18M CHF 6-K/A · filed 2023-12-21 | 6.08M CHF 6-K/A · filed 2023-12-21 | ||
| 2022-12-31 | 11.99M CHF 20-F · filed 2025-05-15 | 21.97M CHF 20-F · filed 2023-03-30 | ||
| 2022-06-30 | 7.28M CHF 6-K/A · filed 2023-12-21 | 13.29M CHF 6-K/A · filed 2023-12-21 | ||
| 2021-12-31 | 18.66M CHF 20-F · filed 2024-04-18 | |||
| 2021-06-30 | 5.58M CHF 6-K/A · filed 2022-09-14 | 9.65M CHF 6-K/A · filed 2022-09-14 | ||
| 2020-12-31 | 16.12M CHF 20-F · filed 2023-03-30 | |||
| 2019-12-31 | 17.44M CHF 20-F · filed 2022-03-10 | |||
| 2018-12-31 | 8.13M CHF 20-F · filed 2021-03-11 | |||
| 2017-12-31 | 3.73M CHF 20-F · filed 2020-04-27 |